These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 34572867)
1. Development and Validation of an HPLC Method for Analysis of Topotecan in Human Cerebrospinal Fluid and Its Application in Elimination Evaluation of Topotecan after Intraventricular Injection. Yoshikawa N; Yamada A; Yokota T; Yamada Y; Kinoshita M; Moritake H; Ikeda R Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572867 [TBL] [Abstract][Full Text] [Related]
2. Intrathecal administration of topotecan in nonhuman primates. Blaney SM; Cole DE; Godwin K; Sung C; Poplack DG; Balis FM Cancer Chemother Pharmacol; 1995; 36(2):121-4. PubMed ID: 7767947 [TBL] [Abstract][Full Text] [Related]
3. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Blaney SM; Cole DE; Balis FM; Godwin K; Poplack DG Cancer Res; 1993 Feb; 53(4):725-7. PubMed ID: 8428353 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors. Baker SD; Heideman RL; Crom WR; Kuttesch JF; Gajjar A; Stewart CF Cancer Chemother Pharmacol; 1996; 37(3):195-202. PubMed ID: 8529278 [TBL] [Abstract][Full Text] [Related]
5. Microbore HPLC method with online microdialysis for measurement of topotecan lactone and carboxylate in murine CSF. Leggas M; Zhuang Y; Welden J; Self Z; Waters CM; Stewart CF J Pharm Sci; 2004 Sep; 93(9):2284-95. PubMed ID: 15295789 [TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid. Sung C; Blaney SM; Cole DE; Balis FM; Dedrick RL Cancer Res; 1994 Oct; 54(19):5118-22. PubMed ID: 7923128 [TBL] [Abstract][Full Text] [Related]
7. Intrathecal topotecan in adult patients with neoplastic meningitis. Gammon DC; Bhatt MS; Tran L; Van Horn A; Benvenuti M; Glantz MJ Am J Health Syst Pharm; 2006 Nov; 63(21):2083-6. PubMed ID: 17057045 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of fluconazole in the cerebrospinal fluid of children with hydrocephalus. Bafeltowska JJ; Buszman E Chemotherapy; 2005 Oct; 51(6):370-6. PubMed ID: 16227694 [TBL] [Abstract][Full Text] [Related]
10. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer. Tran HC; Gardner S; Weiner HL; Liebes LF; Finlay JL J Oncol Pharm Pract; 2014 Jun; 20(3):229-32. PubMed ID: 23929729 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis. Fleischhack G; Jaehde U; Bode U Clin Pharmacokinet; 2005; 44(1):1-31. PubMed ID: 15634030 [TBL] [Abstract][Full Text] [Related]
12. The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluid. Zamboni WC; Lüftner DI; Egorin MJ; Schweigert M; Sezer O; Richter T; Natale JJ; Possinger K Ann Oncol; 2001 Jan; 12(1):119-22. PubMed ID: 11249038 [TBL] [Abstract][Full Text] [Related]
13. Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates. Salzer W; Widemann B; McCully C; Adamson PC; Balis FM Cancer Chemother Pharmacol; 2001 Sep; 48(3):235-40. PubMed ID: 11592346 [TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic assay for the determination of total and free topotecan in the presence and absence of anti-topotecan antibodies in mouse plasma. Chen J; Balthasar JP J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):183-92. PubMed ID: 15664349 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylguanine in the nonhuman primate. Berg SL; Murry DJ; McCully CL; Godwin K; Balis FM Clin Cancer Res; 1998 Nov; 4(11):2891-4. PubMed ID: 9829757 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid. Madu A; Cioffe C; Mian U; Burroughs M; Tuomanen E; Mayers M; Schwartz E; Miller M Antimicrob Agents Chemother; 1994 Sep; 38(9):2111-5. PubMed ID: 7811028 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic monitoring of cerebrospinal fluid vancomycin concentrations and analysis of their influencing factors in neurosurgical intensive care unit patients]. Yao M; Li J; Shi L; Li Y; Wang L; Guan X; Ouyang B Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct; 31(10):1252-1257. PubMed ID: 31771724 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of the HPLC method for simultaneous estimation of Paclitaxel and topotecan. Jain A; Gulbake A; Jain A; Shilpi S; Hurkat P; Kashaw S; Jain SK J Chromatogr Sci; 2014 Aug; 52(7):697-703. PubMed ID: 23843442 [TBL] [Abstract][Full Text] [Related]
19. A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma. Zamboni WC; Gajjar AJ; Mandrell TD; Einhaus SL; Danks MK; Rogers WP; Heideman RL; Houghton PJ; Stewart CF Clin Cancer Res; 1998 Oct; 4(10):2537-44. PubMed ID: 9796988 [TBL] [Abstract][Full Text] [Related]
20. Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration. Li X; Sun S; Ling X; Chen K; Wang Q; Zhao Z Eur J Clin Pharmacol; 2017 Dec; 73(12):1599-1607. PubMed ID: 28849406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]